结肠粘膜基因表达特征在患有长期性结肠炎新生病进展的患者中
Lene Alsøe1,2, Stephan Andreas Brackmann2,3, Yohan Lefol2,4
1Department of Microbiology, Oslo University Hospital, Oslo, Norway.
Clinical and experimental gastroenterology
|September 24, 2025
概括
发生癌症的性结肠炎 (UC) 患者表现出明显的炎症性粘膜基因表达. 这表明免疫反应减弱,可能阻碍它们与恶性转变作斗争的能力.
科学领域:
- 胃肠病学 胃肠病学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 长期存在的粘膜炎是大肠炎相关结直肠癌 (CA-CRC) 的可疑驱动因素.
- 并非所有性结肠炎 (UC) 患者都会发展CA-CRC,这表明其他因素也会影响癌症的进展.
- 致癌的早期分子事件可能发生在远离瘤的非新生体粘膜中.
研究的目的:
- 调查进展为瘤 (进展者) 的UC患者与非进展者相比是否具有明显的分子炎症特征.
- 确定UC进展者与非进展者的非新生性结肠粘膜中的分子差异.
主要方法:
- 使用微阵列,从UC进展者和非进展者的143个粘膜活检中进行了转录基因分析.
- 基因组本体学分析以确定丰富的生物过程.
- 免疫组织化学测试以评估邻近的粘膜活检中的淋巴细胞透.
主要成果:
- 与非进展者相比,UC进展者表现出明显的基因表达特征,与529个放松调节的基因相比,即使调整了疾病持续时间.
- 进展者的炎症性粘膜对适应性免疫反应和补充活性有负面丰富.
- 进展者显示了更少的透B细胞和更少的淋巴结合物,支持免疫细胞透和活动的减少.
结论:
- 炎症的结肠粘膜在UC患者谁进步到发育不良或癌症有一个不同的基因表达特征比非进步者.
- 这种独特的形状表明,在进步者中,免疫细胞吸引力和透率降低.
- 进展者可能具有对恶性转变产生适应性免疫反应的能力受损.
更多相关视频
相关概念视频
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
903
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
903
02:07Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
01:30Inflammatory Bowel Disease II: Crohn's Disease
960
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
960
01:29Drugs for Treatment of Ulcerative Colitis in IBD
460
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
460
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
1.1K
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.1K
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
643
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
643